The Impact of COVID-19 on Dermatology Clinical Trials
- PMID: 32805216
- PMCID: PMC7427595
- DOI: 10.1016/j.jid.2020.06.032
The Impact of COVID-19 on Dermatology Clinical Trials
Figures
Comment in
-
Clinical Research after COVID-19: Embracing a New Normal.J Invest Dermatol. 2021 Mar;141(3):481-483. doi: 10.1016/j.jid.2020.08.004. Epub 2020 Sep 2. J Invest Dermatol. 2021. PMID: 32890628 Free PMC article.
References
-
- ClinicalTrials.gov How to edit your study record. https://clinicaltrials.gov/ct2/manage-recs/how-edit 2020 (accessed 5 June 2020)
-
- European Medicines Agency Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic, version 3. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/gui... 2020 (accessed 6 May 2020)
-
- Ledford H. Coronavirus shuts down trials of drugs for multiple other diseases. Nature News. https://www.nature.com/articles/d41586-020-00889-6 2020 (accessed 27 April 2020) - PubMed
-
- McDermott M.M., Newman A.B. Preserving clinical trial integrity during the coronavirus pandemic. JAMA. 2020;323:2135–2136. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
